Global Mice Model Market to Grow at 9% CAGR, Driven by Preclinical Research & Personalized Medicine 2030

The global mice model market is set to witness a growth rate of ~9% in the next 5 years. Increasing demand for personalized medicine, growing application in preclinical studies, rising prevalence of chronic and infectious diseases, advancements in genetic engineering technologies, and strong investment in biomedical research, are some of the key factors driving the mice model market. 

A mice model refers to a laboratory mouse utilized in scientific research focusing on the human diseases, genes, and responses to drug. Due to the similarities of mice with humans genetically, biologically, and behaviorally, mice have been established as model organisms in preclinical studies. These models would be either naturally occurring or genetically engineered (for example, knockout or transgenic) or humanized to better replicate a given disease condition. Thus, mice models are important for understanding the mechanism of a disease, as well as for drug discovery, evaluation of drug efficacy and safety, and in personalized medicine and therapeutic development.

🔗 Want deeper insights? Download the sample report:
https://meditechinsights.com/mice-model-market/request-sample/

Increasing demand for personalized medicine to drive market growth

As the need for personalized medicine increases, the market for mice models is growing, as these require fine, predictive models that simulate human biological response. Genetically engineered mice including humanized models provide avenues to study individual genetic variations and disease mechanisms. It helps researchers to identify biomarkers, measure drug response of the patient, and better targeted therapies. Because of the growth in genomics and diagnostics measures, pharmaceutical and biotech industries rely more on mouse models to optimize preclinical testing, improve translational results, reduce clinical trial failures, and, ultimately, accelerate personalized treatment development.

Advancements in gene‑editing (CRISPR/Cas9) – A key market trend

Advances in gene-editing technologies, particularly CRISPR/Cas9, have transformed the mice model market, by creating mutated mice fast and with precision and lower cost. These tools enable researchers to create knockout, knock-in, and humanized mice models that have the ability to mimic specific human genetic mutations and diseases with utmost accuracy. Such accuracy renders the mice model more relevant in preclinical studies, especially for complicated diseases like cancer, neurological disorders, and metabolic syndromes. Multiplex editing is another aspect that CRISPR enables, which allows the study of gene interactions. CRISPR-based gene editing is accelerating drug discovery, functional genomics, and personalized medicine research using mice models.

 Competitive Landscape Analysis

The global mice model market is marked by the presence of established and emerging market players such as Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Cyagen, Janvier Labs, Shanghai Model Organisms Center, Inc., Harbour BioMed, GemPharmatech, and Hera Biolabs; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Gain a competitive edge-request a sample report now! 
https://meditechinsights.com/mice-model-market/request-sample/

Global Mice Model Market Segmentation

This report by Medi-Tech Insights provides the size of the global mice model market at the regional- and country-level from 2023 to 2030. The report further segments the market based on model type and service, technology, application, and end user.

Market Size & Forecast (2023-2030), By Model Type and Service, USD Million

• Model Type
• Inbred Mice
• Outbred Mice
• Genetically Modified Mice
• Hybrid Mice
• Services
• Cryopreservation
• Breeding
• Rederivation
• Quarantine
• Other Services

Market Size & Forecast (2023-2030), By Technology, USD Million

• CRISPR/Cas9
• Embryonic Stem Cell Injection
• Microinjection
• Nuclear Transfer
• Others

Market Size & Forecast (2023-2030), By Application, USD Million

• Oncology
• Metabolic Diseases
• Immunology
• Neurology
• Cardiovascular Diseases
• Others

Market Size & Forecast (2023-2030), By End User, USD Million

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Latin America
• Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com